Patents by Inventor Jason R. Zbieg

Jason R. Zbieg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted Amine Compounds, Compositions and Methods of Use
    Publication number: 20250122171
    Abstract: The present disclosure provides compounds that are useful for the treatment of conditions mediated by MRGPRX2. Also provided are pharmaceutical compositions containing such compounds, and methods of treatment using such compounds.
    Type: Application
    Filed: September 18, 2024
    Publication date: April 17, 2025
    Inventors: Stefan Gahbauer, Jason R. Zbieg, Robert L. Dow, Liang Zhao, Craig Stivala
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20240208919
    Abstract: The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
    Type: Application
    Filed: September 21, 2023
    Publication date: June 27, 2024
    Applicant: Genentech, Inc.
    Inventors: Jason R. Zbieg, Paul Powell Beroza
  • Therapeutic compounds and methods of use
    Patent number: 11787775
    Abstract: The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: October 17, 2023
    Assignee: Genentech, Inc.
    Inventors: Jason R. Zbieg, Paul Powell Beroza
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20230054741
    Abstract: The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
    Type: Application
    Filed: July 22, 2021
    Publication date: February 23, 2023
    Applicant: Genentech, Inc.
    Inventors: Jason R. Zbieg, Paul Powell Beroza